Core Outcome Measures in Effectiveness Trials

FP7 International Advisory Group Membership

The following members form the FP7 International Advisory Group.

Professor Jacques Demotes-Mainard (ECRIN)

Jacques Demotes-Mainard, MD-PhD-MBA, is Professor of Cell Biology, has a background in clinical neurology and a research curriculum as a basic neuroscientist, then as chair of a clinical research centre. Since 2004, he co-ordinates the European Clinical Research Infrastructure Network (ECRIN, www.ecrin.org), funded by the FP6, then FP7 as the ESFRI-roadmap European infrastructure for clinical trials. Since 2005 advisor, then deputy director of the Biology and Health research department at the French Ministry of Higher Education and Research. Chair of the working group on risk based approach in the OECD initiative to facilitate international collaboration in clinical trials.
 

 

Dr Irmgard Eichler (EMA)

Irmgard Eichler is Professor of Paediatrics and is currently Scientific Administrator in Paediatric Medicines Section at the European Medicines Agency (EMA). She qualified in medicine at the Vienna University Medical School and subsequently completed clinical training in Austria, South Africa and the US. Irmgard undertook research training in Paediatric medicine in Austria before completing a Postdoctoral Fellowship in the Division of Allergy & Pulmonary Diseases, at the Children's Hospital at Stanford, Stanford University Medical Center in California.

Before joining the paediatric team at the EMA, Irmgard worked at the University Children’s Hospital in Vienna. She held positions as the Director of the CF-Center, Head of Pulmonary Function Lab and as the Head of the Paediatric Allergology/Pulmonology Working Group. Irmgard has been involved in a number of other professional activities including Senior Clinical Specialist, Pediatric Pulmonology at the Prince Court Medical Center, Kuala Lumpur, member for Austria of the WHO Working Group on Health Promotion for Children and Adolescents in Hospital, expert for cystic fibrosis with the European Medicines Agency and investigator for several national and international clinical trials.
 

 

Professor David Flum (PCORI, Surgical Outcomes Club)

Dr. David Flum is a gastrointestinal surgeon and outcomes researcher at the University of Washington. He holds the rank of Professor in the Schools of Medicine, Public Health, and Pharmacy, and serves as the Director of the Surgical Outcomes Research Center (SORCE) and Associate Chair for Research in the Department of Surgery. He earned a Masters Degree in Public Health in the field of health services research while in the Robert Wood Johnson Clinical Scholars Program at the University of Washington. Dr. Flum has developed a national reputation as a surgical epidemiologist and outcomes researcher, becoming a leader in bridging clinical care and public health issues. His work is aimed at improving healthcare by studying the impact of surgery by identifying processes of care that work and encouraging their use.

Dr. Flum is Medical Director of CERTAIN (http://www.becertain.org), a patient-centered research network focused on conducting comparative studies of healthcare treatments and technology. He also was the founder and Medical Director (2005-2011) and currently serves as Research and Development Lead of the Surgical Care and Outcomes Assessment Program (SCOAP), a quality of care improvement program providing hospital-specific data feedback and best practices regarding processes of care and outcomes to over 55 Washington State hospitals. In 2011, Dr. Flum was appointed to the Methodology Committee of the federal Patient-Centered Outcomes Research Institute (PCORI). He is also the Chair of the American College of Surgeons’ Surgical Research Committee.
 

 

Dr Piero Olliaro (WHO)

Piero has been working for WHO/TDR in Geneva for the last 20 years covering positions in R&D, capacity building and applied field research. Currently he leads a unit on biomedical intervention and implementation research on tropical diseases (NTDs, malaria and tuberculosis). Before TDR he has worked in academia, public health and the private pharmaceutical sector. His background spans over bench and field research and his work bridges research and policy, academia and public health. Developing methodologies is one of his main current themes. MD, PhD, HRD (Habilitation à Diriger les Recherches, Grenoble), infectious diseases specialist, member of the French Académie Nationale de Médecine, Visiting Professor U. Oxford, Honorary Research Fellow with the LSTM; 240 papers indexed in Pubmed.
 

 

Dr Sean Tunis

Dr Sean Tunis
Sean Tunis, MD, MSc. is the President and Chief Executive Officer of the Center for Medical Technology Policy in Baltimore, Maryland. CMTP’s main objective is to improve the quality, relevance and efficiency of clinical research by providing a neutral forum for collaboration among experts, stakeholders and decision makers. Dr. Tunis was a member of the Institute of Medicine Committee on Initial National Priorities for Comparative Effectiveness Research. He advises a wide range of domestic and international public and private health care organizations on issues of comparative effectiveness, evidence based medicine, clinical research, reimbursement and health technology policy.

Through September of 2005, Dr. Tunis was the Chief Medical Officer at the Centers for Medicare and Medicaid Services (CMS), where he had lead responsibility for clinical policy for the Medicare and Medicaid programs. Previously he served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S. Senate, where he worked on pharmaceutical and device policy issues.

Dr. Tunis trained at the University of California in Los Angeles and the University of Maryland in Internal Medicine and Emergency Medicine, and holds adjunct faculty positions at the Center for Health Policy at Stanford University, the Department of Internal Medicine at the Johns Hopkins School of Medicine, and the Department of Surgery at the University of California at San Francisco.
 

 

Ms Liz Whamond (Cochrane Consumer Network)

Ms Liz Whamond
Sean Tunis, MD, MSc. is the President and Chief Executive Officer of the Center for Medical Technology Policy in Baltimore, Maryland. CMTP’s main objective is to improve the quality, relevance and efficiency of clinical research by providing a neutral forum for collaboration among experts, stakeholders and decision makers. Dr. Tunis was a member of the Institute of Medicine Committee on Initial National Priorities for Comparative Effectiveness Research. He advises a wide range of domestic and international public and private health care organizations on issues of comparative effectiveness, evidence based medicine, clinical research, reimbursement and health technology policy.

Through September of 2005, Dr. Tunis was the Chief Medical Officer at the Centers for Medicare and Medicaid Services (CMS), where he had lead responsibility for clinical policy for the Medicare and Medicaid programs. Previously he served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S. Senate, where he worked on pharmaceutical and device policy issues.

Dr. Tunis trained at the University of California in Los Angeles and the University of Maryland in Internal Medicine and Emergency Medicine, and holds adjunct faculty positions at the Center for Health Policy at Stanford University, the Department of Internal Medicine at the Johns Hopkins School of Medicine, and the Department of Surgery at the University of California at San Francisco.
 

 

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.